References
- 1
Adams J M, Taylor A E, Crowley Jr W F, Hall J E.
Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology
of polycystic ovarian syndrome.
J Clin Endocrinol Metab.
2004;
89
4343-4350
- 2
Aizawa H, Niimura M.
Elevated serum insulin-like growth factor-1 (IGF‐1) levels in women with postadolescent
acne.
J Dermatol.
1995;
22
249-252
- 3
Amer S A, Li T C, Bygrave C, Sprigg A, Saravelos H, Cooke I D.
An evaluation of the inter-observer and intra-observer variability of the ultrasound
diagnosis of polycystic ovaries.
Hum Reprod.
2002;
17
1616-1622
- 4
Asuncion M, Calvo R M, San Millan J L, Sancho J, Avila S, Escobar-Morreale H F.
A prospective study of the prevalence of the polycystic ovary syndrome in unselected
Caucasian women from Spain.
J Clin Endocrinol Metab.
2000;
85
2434-2438
- 5
Azziz R, Woods K S, Reyna R, Key T J, Knochenhauer E S, Yildiz B O.
The prevalence and features of the polycystic ovary syndrome in an unselected population.
J Clin Endocrinol Metab.
2004;
89
2745-2749
- 6
Balen A H, Laven J S, Tan S L, Dewailly D.
Ultrasound assessment of the polycystic ovary: international consensus definitions.
Hum Reprod Update.
2003;
9
505-514
- 7
Barbieri R L, Makris A, Randall R W, Daniels G, Kistner R W, Ryan K J.
Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained
from women with hyperandrogenism.
J Clin Endocrinol Metab.
1986;
62
904-910
- 8
Bili H, Laven J, Imani B, Eijkemans M J, Fauser B C.
Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic
oligo-amenorrhoeic infertile women of reproductive years.
Eur J Endocrinol.
2001;
145
749-755
- 9
Cappel M, Mauger D, Thiboutot D.
Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone
sulfate, and dihydrotestosterone and acne lesion counts in adult women.
Arch Dermatol.
2005;
141
333-338
- 10
Cara J F.
Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian
androgen production.
Horm Res.
1994;
42
49-54
- 11
Carmina E.
Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
Minerva Ginecol.
2004;
56
1-6
- 12
Carmina E, Wong L, Chang L, Paulson R J, Sauer M V, Stanczyk F Z, Lobo R A.
Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
Hum Reprod.
1997;
12
905-909
- 13
Cela E, Robertson C, Rush K, Kousta E, White D M, Wilson H, Lyons G, Kingsley P, McCarthy M I,
Franks S.
Prevalence of polycystic ovaries in women with androgenic alopecia.
Eur J Endocrinol.
2003;
149
439-442
- 14
Cussons A J, Stuckey B G, Walsh J P, Burke V, Norman R J.
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists
in diagnosis and management.
Clin Endocrinol (Oxf).
2005;
62
289-295
- 15
De Leo V, Lanzetta D, D'Antona D, la Marca A, Morgante G.
Hormonal effects of flutamide in young women with polycystic ovary syndrome.
J Clin Endocrinol Metab.
1998;
83
99-102
- 16
Dramusic V, Goh V H, Rajan U, Wong Y C, Ratnam S S.
Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome
in Singaporean adolescents.
J Pediatr Adolesc Gynecol.
1997;
10
125-132
- 17
Dunaif A.
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for
pathogenesis.
Endocr Rev.
1997;
18
774-800
- 18
ESHRE/ASRM .
Revised 2003 consensus on diagnostic criteria and long-term health risks related to
polycystic ovary syndrome.
Fertil Steril.
2004;
81
19-25
- 19
Gilling-Smith C, Story H, Rogers V, Franks S.
Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic
ovary syndrome.
Clin Endocrinol (Oxf).
1997;
47
93-99
- 20
Hassan M A, Killick S R.
Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic
ovary syndrome is not associated with subfecundity or subfertility.
Fertil Steril.
2003;
80
966-975
- 21
Herter L D, Magalhaes J A, Spritzer P M.
Association of ovarian volume and serum LH levels in adolescent patients with menstrual
disorders and/or hirsutism.
Braz J Med Biol Res.
1993;
26
1041-1046
- 22
Iwashita M, Mimuro T, Watanabe M, Setoyama T, Matsuo A, Adachi T, Takeda Y, Sakamoto S.
Plasma levels of insulin-like growth factor-I and its binding protein in polycystic
ovary syndrome.
Horm Res.
1990;
33
21-26
- 23
Jonard S, Dewailly D.
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism,
may be the main culprit for the follicular arrest.
Hum Reprod Update.
2004;
10
107-117
- 24
Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D.
Ultrasound examination of polycystic ovaries: is it worth counting the follicles?.
Hum Reprod.
2003;
18
598-603
- 25
Legro R S, Chiu P, Kunselman A R, Bentley C M, Dodson W C, Dunaif A.
Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but
do not predict metabolic or reproductive phenotype.
J Clin Endocrinol Metab.
2005;
90
2571-2579
- 26
Loucks T L, Talbott E O, McHugh K P, Keelan M, Berga S L, Guzick D S.
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women
with polycystic ovary syndrome?.
Fertil Steril.
2000;
74
547-552
- 27
Matsuda M, DeFronzo R.
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison
with the euglycemic insulin clamp.
Diabetes Care.
1999;
22
1462-1470
- 28
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man.
Diabetologia.
1985;
28
412-419
- 29
Michelmore K F, Balen A H, Dunger D B, Vessey M P.
Polycystic ovaries and associated clinical and biochemical features in young women.
Clin Endocrinol (Oxf).
1999;
51
779-786
- 30
Najmabadi S, Wilcox J G, Acacio B D, Thornton M H, Kolb B A, Paulson R J.
The significance of polycystic-appearing ovaries versus normal-appearing ovaries in
patients with polycystic ovary syndrome.
Fertil Steril.
1997;
67
631-635
- 31
Norman R J, Hague W M, Masters S C, Wang X J.
Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances
in insulin and lipid profiles as those with polycystic ovary syndrome.
Hum Reprod.
1995;
10
2258-2261
- 32
O'Driscoll J B, Mamtora H, Higginson J, Pollock A, Kane J, Anderson D C.
A prospective study of the prevalence of clear-cut endocrine disorders and polycystic
ovaries in 350 patients presenting with hirsutism or androgenic alopecia.
Clin Endocrinol (Oxf).
1994;
41
231-236
- 33
Pache T D, de Jong F H, Hop W C, Fauser B C.
Association between ovarian changes assessed by transvaginal sonography and clinical
and endocrine signs of the polycystic ovary syndrome.
Fertil Steril.
1993;
59
544-549
- 34
Raskauskiene D, Jones P W, Govind A, Obhrai M, Clayton R N.
Do polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in
sisters of women with polycystic ovary syndrome?.
J Clin Endocrinol Metab.
2005;
90
2063-2067
- 35
Takahashi K, Uchida A, Yamasaki H, Ozaki T, Kitao M.
Transvaginal ultrasonic assessment of the response to clomiphene citrate in polycystic
ovarian syndrome.
Fertil Steril.
1994;
62
48-53
- 36
Thierry van Dessel H J, Lee P D, Faessen G, Fauser B C, Giudice L C.
Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
J Clin Endocrinol Metab.
1999;
84
3030-3035
- 37
van der Westhuizen S, van der Spuy Z M.
Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
Ultrasound Obstet Gynecol.
1996;
7
335-341
- 38
Vendola K A, Zhou J, Adesanya O O, Weil S J, Bondy C A.
Androgens stimulate early stages of follicular growth in the primate ovary.
J Clin Invest.
1998;
101
2622-2629
MD Susanne Hahn
Division of Endocrinology
Department of Medicine
University of Duisburg-Essen
Hufelandstrasse 55
45122 Essen
Germany
Phone: + 492017232854
Fax: + 49 20 17 23 56 55
Email: susanne.hahn@uni-essen.de.
